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Background: Cluster of differentiation 1 (CD1) represents a family of proteins which is involved in lipid-based an-
tigen presentation. Primarily, antigen presenting cells, like B cells, express CD1 proteins. Here, we examined the
cell-surface distribution of CD1d, a subtype of CD1 receptors, on B lymphocytes.
Methods: Fluorescence labelingmethods, including ﬂuorescence resonance energy transfer (FRET), were employed
to investigate plasma membrane features of CD1d receptors.
Results: High FRET efﬁciency was observed between CD1d and MHC I heavy chain (MHC I-HC), β2-microglobulin
(β2m) andMHC II proteins in the plasmamembrane. In addition, overexpression of CD1d reduced the expression
of MHC II and increased the expression of MHC I-HC and β2m proteins on the cell-surface. Surprisingly, β2m de-
pendent CD1d isoform constituted only ~15% of the total membrane CD1d proteins. Treatment of B cells with
methyl-β-cyclodextrin (MβCD) / simvastatin caused protein rearrangement; however, FRET demonstrated
only minimal effect of these chemicals on the association between CD1d and GM1 ganglioside on cell-surface.
Likewise, a modest effect was only observed in a co-culture assay between MβCD/simvastatin treated C1R–36
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CD1d cells and invariant natural killer T cells on measuring secreted cytokines (IFNγ and IL4). Furthermore,
CD1d rich regions were highly sensitive to low concentration of Triton X-100. Physical proximity between
CD1d, MHC and GM1 molecules was also detected in the plasma membrane.
Conclusions: An intricate relationship between CD1d, MHC, and lipid species was found on the membrane of
human B cells.
General signiﬁcance: Organization of CD1d on the plasmamembranemight be critical for its biological functions.42© 2013 Published by Elsevier B.V.434R
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R1. Introduction
Antigen presentation is a deﬁning mechanism in the adaptive im-
mune system. While several decades of information are available about
peptide antigen presentation, throughmajor histocompatibility complex
(MHC)molecules, in the activation of conventional T cells, similar roles of
lipids in antigen presentation have gained signiﬁcant attention beginning
only in the last couple of decades [1–3]. The non-polymorphic transmem-
brane glycoproteins known as Cluster of Differentiation (CD1) were
found to present these non-peptide antigens to a distinct subset of T66
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chim. Biophys. Acta (2013), hcells [3,4]. In fact, these CD1molecules, encoded on human chromosome
1, resemble MHC I heavy chain (MHC I-HC) in physical structure [3,5–7]
and MHC II molecules in function, mainly endosomal surveillance [6,8],
thus possessing an admixture of features which have led to the hypothe-
sis that these molecules have diverged from a common ancestral gene.
Interestingly, MHC I and CD1d also share the chaperones, calnexin and
calreticulin, which are important for their appropriate folding [9,10].
In human, CD1 a, -b and -c molecules are placed in group I CD1 while
CD1d is kept separately in group II [7,10,11]. CD1d- restricted natural
killer T (NKT) cells release copious amount of both Th1 and Th2 type
cytokines and chemokines upon engagement with CD1d receptors,
underscoring the roles of CD1d in immunoregulation [12,13]. Most earli-
er studies demonstrated the trafﬁcking behavior of CD1 from the plasma
membrane to the intracellular endosomal membrane compartment and
vice versa [4,6,14–21]; these studies provided evidence that CD1 mole-
cules sample antigens in the endocytic system but the membrane orga-
nization of these receptors which could inﬂuence such biological
behaviors of thesemolecules has not been explored in detail yet. Further-
more, owing to the broad role played by CD1d in B lymphocytes, which
came into prominence recently due to its role in sustaining antibody re-
sponses [22,23] and for the maintenance of invariant natural killer Td, GM1 ganglioside proximity and low detergent sensitive membrane
ttp://dx.doi.org/10.1016/j.bbagen.2013.10.030
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(iNKT) cells [24], we focused our studies on this molecule, which is also
the only CD1 isoform expressed bymouse [7,25]. Two isoforms of CD1d
have been observed on the surface of cells: one that is physically bound
to β2-microglobulin (β2m) and the other that is independently present
without β2m [11,26]. Hereon, we will address these isoforms as β2m-
dependent and β2m-independent CD1d proteins. Biochemical studies
also illustrated that CD1d is in association with MHC II molecules in
the plasma membrane [25] and with invariant chain in membrane-
bound intracellular compartments [27]. These observations suggested
that these molecules might be in close vicinity of each other and most
probably in some speciﬁc domains like lipid-rafts. In a murine cell line
system, CD1d was distinctly found to be located in the lipid-rafts and
the disruption of lipid-rafts by methyl-β-cyclodextrin (MβCD) was
found to interfere with the NKT cell activational responses [28–31].
Furthermore, we reported the co-existence of MHC I and MHC II in
nanodomains of various types of cells using ﬂuorescence resonance
energy transfer (FRET) [32–36] and electron microscopy [33]. Since,
co-immunoprecipitation wasmainly used to detect protein–protein in-
teractions in the case of CD1d, even for the membrane fractions, which
can present artefactual interactions and is difﬁcult to reproduce, we
thought to utilize FRET, which can demonstrate physiological and
dynamic interactions and is a better approach to investigate the distri-
bution of CD1d proteins in the plasmamembrane. FRET is very sensitive
to changes in distance because the rate of energy transfer is inversely
proportional to the sixth power of the distance separating the donor
and acceptor ﬂuorophores. This sensitivity to distance makes FRET a
useful tool for investigating protein–protein interactions within the
range of 1–10 nm. In this study, we demonstrate that CD1d proteins
are indeed proximal to MHC proteins and are present in detergent sen-
sitive domains of the membrane in lymphocytes. Surprisingly, β2m de-
pendent CD1d comprised only a small fraction of CD1d proteins on the
membrane (~15%). We also noted that CD1d rich regions were mildly
affected by cholesterol modulation, but were signiﬁcantly altered by
low concentration of Triton X-100 (TX100). Likewise, a co-culture
assay between C1R–CD1d and iNKT cells also demonstrated the partial
dependence of CD1d rich regions on cholesterol. In summary, CD1d
seems to have an intricate relationship with MHC proteins and mem-
brane lipids, and it also can apparently form larger protein–protein or
protein–lipid complexes in the membrane of C1R–CD1d cells.
2. Materials and methods
2.1. Cell lines
The HLA-C expressing mutant B lymphoid cell line, C1R [37], stably
expressing full-length CD1d was used in this study. The characterization
of this cell line, including transfection details has been described else-
where [38]. To obtain cells with uniform CD1d expression, the
transfected C1R cells were magnetically sorted using 27.1.9 CD1d anti-
body and pan anti-mouse secondary antibody conjugated magnetic
Dynabeads (Life Technologies/Invitrogen, Budapest, Hungary) following
themanufacturer's instructions. Once sorted, the cellswere referred to as
C1R–CD1d. The cells were grown in RPMI media containing 10% new-
born calf serum (NCS), with the inclusion of drug G418 at 300μg/ml con-
centration unless stated otherwise.
2.2. Antibodies
The following monoclonal antibodies (Mabs) were used: the pan-
MHC-I W6/32 (recognizes MHC I-HC associated with β2m, IgG2a)
[39,40] , HC-10 (recognizes free MHC I-HC, IgG2a) [40–43], L368
(anti-β2m, IgG1) [44], L243 (anti-MHC-DR, IgG2a) [45], OKT9 (anti-
transferrin receptor (TfR), IgG1) [46], 51.1.3 (anti-CD1d, IgG2b) and
27.1.9 (anti-CD1d, IgG1) [47]. Antibodies were prepared from hybrid-
oma supernatants according to the standard protocol by Sepharose A af-
ﬁnity chromatography. Antibodies were coupled to Alexa 546- andPlease cite this article as: D. Shrestha, et al., CD1d favors MHC neighborhoo
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Alexa 647-succinimidyl ester dyes following the manufacturer's in-
structions (Molecular Probes, Invitrogen) and the dye to protein ratios
were calculated based on the spectrophotometric absorbance values
of the proteins. MEM75 antibody, against TfR [48] was a kind gift from
Václav Horejsí (Institute of Molecular Genetics, Academy of Sciences,
Prague, Czech Republic).
2.3. Cell labeling
For each sample, approximately one million freshly harvested cells
were taken in 50 μl volume of PBS buffer (pH 7.4) containing 1mg/ml
BSA and 0.01% sodium azide. A saturating concentration of the dye con-
jugated antibodies was added to these cells, and the mixed suspension
was incubated in a dark environment for 30min on ice. After the incu-
bation, these cells were washed twice with ice-cold PBS buffer in
order to remove unbound antibodies. Finally, the cells were suspended
in 1% formaldehyde solution, and they were kept at 4 °C until the
measurements were performed in a ﬂow cytometer or a confocal
microscope.
2.4. Quantitation of membrane receptors
In order to determine the expression level of each of the receptors,
QIFIKIT (Dako Cytomation, Glostrup, Denmark) was used according to
the manufacturer's instructions. QIFIKIT is an indirect immunoﬂuores-
cence based method of determining antigen density per cell by ﬂow cy-
tometry. This consists of a series of beads coated with known quantities
of Mabs which emulate cells with deﬁned antigen densities. Specimen
cells were labeled with the primarymouseMab at saturating concentra-
tion. Then, the cells were incubated, in parallel with the QIFIKIT beads,
with FITC dye tagged polyclonal anti-mouse secondary F (abs′) 2. Finally,
a calibration curvewas plotted between the ﬂuorescence intensity of the
individual bead populations against the number of Mab molecules on
these beads. This curve was then used for determining the number of
receptors on the specimen cells by interpolation. For our purpose, ﬂuo-
rescence intensities were measured on a FACSCalibur instrument using
a 530+/−30BP ﬁlter.
2.5. Confocal microscopy
A Zeiss LSM 510 confocal laser scanning microscope (Carl Zeiss
AG, Jena, Germany) with a Plan-Apochromat 40× (NA=1.2) water
immersion objective was used to record the images. An optical slice
(512 × 512-pixels) of 1.5 μm thickness, four-times averaged, was
taken from the top of a cell for co-localization experiments. Simulta-
neously, a multitrack option of the microscope was used to acquire im-
ages to avoid any possible crosstalk between the detection channels.
2.6. Co-localization study of the receptors
The spatial proximity of membrane proteins was studied by image
cross-correlation method at ~200 nm scale. For this purpose, cells
were doubly or triply labeledwithmarkers speciﬁc for distinctmolecular
species but tagged with spectrally different ﬂuorophores. Images were
acquired from the top of the cells as a horizontal optical slice by confocal
microscope. A custom program written in LABVIEW platform was
used for the computational analysis of the cross-correlation coefﬁ-
cient (C) from the image pairs [49,50]. For an image pair ‘x’ and ‘y’,
the image cross-correlation coefﬁcient was calculated by the following
formula:
C ¼
∑i∑ j xi; j− xh i
 
yi; j− yh i
 
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
∑i∑ j xi; j− xh i
 2∑i∑ j yi; j− yh i
 2rd, GM1 ganglioside proximity and low detergent sensitive membrane
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images x and y. Only those pixels that were above the detection thresh-
old in both images were used for analysis. The theoretical maximum is
‘1’ for perfect overlap of proteins (i.e. 100% co-localization); while a
value ‘0’ implies random overlap of proteins and a negative value ‘−1’
indicates an anti-colocalized situation of the two molecules where a
pixel is bright in one channel and dim in the other.255
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2772.7. Flow-cytometric FRET (FCET) experiments
FCET experiments were carried out using FACSArray ﬂow cytometer
(Becton Dickinson, Franklin Lakes, and NJ) equipped with 532 and
633 nm lasers. For this purpose, samples were either singly or doubly
labeled with Alexa-546, Alexa-555 or Alexa-647 dye conjugated probes
and/or antibodies serving as donor and acceptor molecules. Emitted
signals due to 532 laser excitation were collected in the donor
(575 +/− 25) and the transfer (650 LP) channels while the 633 nm
laser excited the acceptor dyes and the signals were collected in the ac-
ceptor channel (650 +/− 10). The obtained FCS data were analyzed
using the ReFleX software [51]. The mean FRET efﬁciencies were then
calculated from roughly 20,000 cells. For two-color three-protein FCET
experiment, similar protocol was used as above except the inclusion
of the third protein as a donor or as an acceptor. The conventional
FRET has two proteins as a FRET pair but this modiﬁed two-color
three-protein FRET has three proteins as FRET pair, and two of these
proteins are combinedly used as a donor or acceptor molecules. This
means two Mabs against two receptors are conjugated to same Alexa
dyes separately. However, they are mixed during cell-labeling and are
used as either donor or acceptor. Thus, two Mabs conjugated to same
Alexa dyes behave together as a unit representing either donor or ac-
ceptor species.T 278279
280
281
282
283
284
285
286
287
288
289O
R
R
E
C
2.8. CD1d and GM1 ganglioside association
Cholera toxin subunit B (CTxB) was used to visualize GM1 ganglio-
sides and 27.1.9 CD1d Mab was used to identify CD1d proteins. For
co-localization assay, the experimentswere performed using the confo-
cal microscope as described above, after labeling each of the species in
the membrane of the cells. Alexa 488 conjugated CTxB was excited by
488nm laser and the signalswere detected through a 505/550nmBPﬁl-
ter while Alexa 647 conjugated CD1d antibody was excited by 632nm
laser and the ﬂuorescence emission was detected through 650 LP ﬁlter.
For the FCET experiment, Alexa 555-CTxB (Invitrogen) was used as a
donor, while Alexa 647–27.1.9 CD1d Mab was used as an acceptor and
the measurements were performed in FACSArray.290
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C2.9. Flow cytometric detergent resistance (FCDR) test
For the kinetic assessment of CD1d enriched membrane regions, an
earlier published protocol based on ﬂow cytometry was followed [52].
Brieﬂy, cells were labeled with Alexa 488 dyes conjugated Mabs or
probes in 50 μl volume of PBS buffer (pH7.4) containing 1mg/ml BSA.
The incubation andwashing of the sampleswere carried out in a similar
fashion as described for other samples in the labeling method. Impor-
tantly, formaldehyde ﬁxation of cells was not done in this experiment.
Measurements were carried out immediately after the sample prepara-
tion using 530+/− 30 BP ﬁlter in FACScan instrument. At ﬁrst, ﬂuores-
cence intensities were recorded without TX100 from all samples
(~50 s), thereafter, various concentrations of ice-cold TX100 was added
to the sample swiftly. It was mixed for a few seconds and the measure-
ments were continued for an additional 5min. The FCS data were ana-
lyzed using ReFleX software. Later, SigmaPlot Version 10 was used to
plot the graph of ﬂuorescence intensity versus time using calculated
data from ReFleX software.Please cite this article as: D. Shrestha, et al., CD1d favors MHC neighborhoo
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2.10. Treatment of cells withmethyl-β-cyclodextrin (MβCD) or simvastatin
Simvastatin and MβCD were purchased from Sigma, and the solu-
tions were made as per the instructions from the company. For experi-
mental purposes, simvastatin was also activated by hydrolysis at
alkaline pH using sodiumhydroxide following themanufacturer's spec-
iﬁcations. Micromolar (μM) concentration of preactivated simvastatin
was used to treat 3–10 million cells in 1% NCS RPMI media for 48 h at
37 °C in a humidiﬁed incubator with a constant supply of air with 5%
CO2. For MβCD treatment, 5–10 million cells, which were cultured in
1% NCS, unless otherwise mentioned, were taken in 1 ml of 0.1% NCS
RPMI media and were incubated with 2 mM MβCD for 40 min or
10 mM MβCD for 15 min at 37 °C. Once the incubation was over, in
both the cases, cells were washed extensively and labeled following
the protocol described above.
2.11. Isolation of iNKT cells from peripheral blood mononuclear cells (PBMC)
PBMC were isolated from human peripheral blood by standard
procedure using Ficoll density gradient centrifugation (Sigma).
Thereafter, iNKT cells were separated from PBMC using human
anti-iNKT magnetic beads (Miltenyi Biotec, Bergisch-Gladbach,
Germany). Sorted iNKT cells were grown in ﬂat bottomed 96 well
plates, which contained α-galactosylceramide (α-gal, Avanti Polar
Lipids, Inc., Alabama, USA) loaded mitomycin-arrested (50 μg/ml for
45min) C1R–CD1d cells in GIBCO OpTmizer™ CTS™ T-Cell Expansion
SFM media (Invitrogen). The medium was also supplemented with 5%
AB human serum (Sera Laboratories International Ltd, West Sussex,
UK), 200 ng/ml of recombinant IL2 (Shenandoah Biotechnology, Inc.,
USA) and 2 μg/ml phytohemagglutinin M (PHA-M, Sigma). Growth of
the cells was carefully monitored over the days with clusters of cells in-
dicating the survival and proliferation of iNKT cells. The concentration
of IL2 was also gradually decreased from 200 ng/ml to 20 ng/ml
(~10 U/ml) during the period of culture. The expanded iNKT cells had
a high purity of N98% when examined by ﬂow cytometry with C21
(anti-Vβ11, IgG2a, Beckman coulter), and OKT3 (anti-CD3, IgG2a).
2.12. iNKT cell activation assay
To determine the effect of membrane cholesterol depletion of
C1R–CD1d cells in iNKT cell activation, a co-culture assay was also de-
signed. In the case of simvastatin study, α-gal (250 ng/ml) was added
to the cells only 4h prior to the completion of 48h of simvastatin incu-
bation, whereas, α-gal was fed to cells for 18 h in the case of MβCD
study. Cells for simvastatin treatment were grown in 1% NCS RPMI me-
diumwhereas forMβCD studywere cultured in 10%NCSRPMImedium.
C1R–CD1d cells were treated either with simvastatin or MβCD as de-
scribed above in the treatment section. Once the reagent treatment
was over, B cells were ﬁxed with 1% formaldehyde for 20 min on ice
and were extensively washed, in order to prevent the reassembly of
cholesterol in the membrane. In the assay, 60,000 C1R–CD1d cells and
20,000 iNKT cells were seeded in each well of the round-bottomed 96
well plates with RPMI medium containing 5% human serum and
20ng/ml recombinant IL2 for 48h at 37°C. Experimentswere performed
in triplicates for each test. Importantly, iNKT cells were grown in 5%
human serum and 20ng/ml recombinant IL2 containing RPMI medium
for at least 48h before it was used for the experiments.
2.13. Statistical analysis
For comparison, either an unpaired t-test or one-way ANOVA to-
gether with Tukey posthoc analysis was performed using SigmaStat
3.5 (GmbH, Germany) depending on the number of groups. Only ‘p’
values b0.05 were considered signiﬁcant. Non signiﬁcant ‘p’ values are
indicated by abbreviation ‘N.S.’, whereas, ‘p’ values b0.05, b0.005, and
b0.0005 are denoted with ∗, ∗∗, and ∗∗∗, respectively on the ﬁgures.d, GM1 ganglioside proximity and low detergent sensitive membrane
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3.1. Expression level of MHC I-HC, β2m,MHC II and CD1d in C1R–CD1d cells
We wanted to evaluate the relationship between CD1d and MHC
molecules on the membrane of B lymphocytes. For this objective,
we selected a B lymphoid cell-line, C1R–CD1d which was used in
various pull-down experiments previously in an attempt to identify
protein interaction partners of CD1d from both plasma membrane
and intracellular compartments [10,11,25]. First, we examined the
level of expression of various receptors on this cell-line by ﬂow cytom-
etry. As depicted in Fig. 1, MHC II was found to be the highest in expres-
sion followed by CD1d while MHC I-HC was almost three and half-fold
lower in expression in comparisonwithMHC II in this cell line. Interest-
ingly, the data obtained from the ﬂuorescently labeled C1R–CD1d cells,
after taking into account dyes-to-antibody ratios, also suggested that
the membrane expression of β2m was higher than that of MHC I-HC
molecules (Fig. 1).TE
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Fig. 1. a) Comparison of expression of various proteins on the surface of C1R–CD1d cells:R
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3.2. Quantitative determination of surface receptors
Fluorescence signals obtained using dye-conjugated antibodies are
relative instead of quantitative indicators of the expression level of pro-
teins. Therefore, we calculated the number of MHC I-HC, β2m, MHC II
and CD1d proteins on the membrane of C1R–CD1d cells using QIFIKIT
(Fig. 1b). In agreement with the ﬂow cytometric ﬂuorescence histo-
grams, MHC II was found to be the most abundant protein in the mem-
brane of C1R–CD1d cells. Likewise, expression of β2m was also higher,
approximately by 18,000 molecules/cell, in comparison to that of MHC
I-HC. MHC I-HC forms a pair with β2m, a conformation detected by
W6/32 antibody [40], and is also known to form self-clusters (oligo-
mers) [33,53]. Therefore, typically the expression of MHC I-HC is higher
than that of β2m proteins in most cells [33]. Hence, in order to identify
the possibility of β2m free unpaired MHC I-HC molecules, we used a
HC-10 antibody, which mainly recognizes HLA-B and -C isoforms of
β2m free MHC I [40]. Using these antibodies, we found that there were
only a few hundreds of β2m free MHC I-HC molecules on the surface
of C1R–CD1d cells. Similarly, two antibodies, 27.1.9 and 51.1.3 hybrid-
oma clones, against CD1d protein demonstrated comparable surface ex-
pression for CD1d proteins (Fig. 1b). Thus, in light of the numerical data,
we concluded that β2m is deﬁnitely greater in numbers than MHC I-HC
and abundant β2m independent CD1d is present on the membrane of
C1R–CD1d cells.366
367
368
369
370
371
372
373
C1R–CD1d cells were labeled with A647 dye conjugated speciﬁc Mabs against MHC I-HC
(W6/32) red, β2m (L368) blue, CD1d (27.1.9 clone) violet, MHC II (L243) green following
protocols described in the Materials and methods section independently. Measurements
were performed using a FACSArray ﬂow cytometer. b) QIFIKIT estimation of the number
of membrane receptors: Cells were labeled according to the protocols provided by the
manufacturer. Brieﬂy, cells were labeled separately with unconjugated antibodies speciﬁc
for each receptor. The mixture of cells and antibodies were incubated on ice for 30 min.
The membrane receptors were saturated with antibodies, then, washing was done using
ice-cold PBS buffer. Next, the samples were incubated with FITC conjugated F (ab′) 2 for
30min on ice and in a dark environment. Finally, after washing twice with ice-cold PBS
buffer, samples were ﬁxed using 1% formaldehyde. The sample measurements were per-
formed immediately by FACSCalibur. The numbers of receptors are presented as
Mean ± S.E.M. In the ﬁgure, CD1da and CD1db indicate staining of CD1d receptors by
51.1.3 and 27.1.9 CD1d Mabs respectively.U
N
C
O3.3. CD1d expression affects expression of membrane MHC proteins
During the period of continuous growth, C1R–CD1d cells had the
tendency of losing the membrane expression of CD1d; hence, giving
rise to CD1d positive (CD1d+ve) and negative (CD1d−ve) population
of C1R cells (Fig. 2a). We realized that such a phenomenon can be used
to determine the effect of CD1d in the membrane expression of MHC
and β2m proteins. Therefore, we compared the surface expression of
these proteins in these two sub-groups. As expected, we observed
marked differences in the expression of these proteins in C1R–CD1d
“+ve” and C1R–CD1d “−ve” cells. β2m expression increased signiﬁ-
cantly in C1R–CD1d “+ve” cells (~46.7±11.5%) in comparison to that
of its expression in C1R–CD1d “−ve” cells thus conﬁrming the role of
CD1d in inﬂuencing the membrane expression of β2m. In addition, we
also observed an increase in the expression of MHC I-HC (~10±2.6%)
and decrease in the expression of MHC II (~31.8 ± 4.6%) proteins in
the plasma membrane of C1R–CD1d “+ve” in comparison with its
C1R–CD1d “−ve” counterparts (Fig. 2b). The comparison of the expres-
sion of these proteins between C1R-Mock cells and C1R–CD1d cells also
revealed a similar pattern (data not shown).Please cite this article as: D. Shrestha, et al., CD1d favors MHC neighborhoo
regions on the surface of B lymphocytes, Biochim. Biophys. Acta (2013), h3.4. Co-localization study of MHC I-HC, β2m, MHC II and CD1d in
C1R–CD1d cells
Previous studies documented that a lot of common features existed
between CD1d and MHC molecules, including antigen presenting
characteristics [10,11,25]. Since MHC I and MHC II molecules exten-
sively co-localize in the plasma membrane [32,33,53], we hypothe-
sized that these molecules might be in the vicinity of CD1d as well.
Alexa 546 and Alexa 647 dyes conjugated to the same L243 antibodyd, GM1 ganglioside proximity and low detergent sensitive membrane
ttp://dx.doi.org/10.1016/j.bbagen.2013.10.030
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Fig. 2. CD1d expression affects expression of membrane MHC proteins: a) Histograms
displaying ﬂuorescence intensities from C1R cells with the following labeling parameters:
Unlabeled (Black), Isotype control (Blue), C1R-Mock cells incubated with CD1d antibody
(Red) and C1R cells containing C1R–CD1d “+ve” and C1R–CD1d “−ve” cells (Green). A
4D5 antibody, IgG1, against ErbB2 protein – an antigen over expressed in breast cancer
cells –was used as an isotype control, where as 27.1.9 CD1d antibodywas used to determine
CD1d expression in C1R cells. Both the antibodies were conjugated to Alexa 647 dyes. b) The
panel shows the change in ﬂuorescence signals in percentage (Mean±S.E.M.) in C1R–CD1d
“+ve” population in comparison with a C1R–CD1d “−ve” population. The expression of re-
ceptors by C1R–CD1d “−ve”populationwas taken as 100%. A dual labeling of receptors of in-
terestwas carried out simultaneously as described in theMaterials andmethods section. One
of the labeled receptors was always CD1d protein while the second receptor was among
MHC I-HC, β2m orMHC II proteins. Measurements were performed by a FACSCalibur instru-
ment equippedwith blue, 488nmAr ion laser, and red, 635nmdiode laser. Positive and neg-
ative populations for CD1dproteinwere gated carefully, and theﬂuorescence signals for each
of the receptors in each populationwere quantiﬁed. Alexa 488 and Alexa 647 dyes conjugat-
ed antibodies were used in this experiment to avoid possible spectral overlap between dyes.
In the ﬁgure, ∗, ∗∗, and ∗∗∗ indicate ‘p’ values b0.05, b0.005, and b0.0005 respectively.
5D. Shrestha et al. / Biochimica et Biophysica Acta xxx (2013) xxx–xxxwere used as a positive control, whereas, GM1 ganglioside and TfR
molecules – which are considered to reside in detergent resistant
and detergent sensitive membrane regions –were used as a negative
control. On performing a co-localization experiment, we observed
that several yellow pixels were predominant in the superimposed
images of CD1d and other proteins (MHC I-HC, MHC II and β2m)
resembling a positive control and indicating conﬁnement of these
proteins in the same regions of themembrane (Fig. 3a). Additionally,
the cross-correlation coefﬁcient values for these proteins were also
remarkably high thus conﬁrming the spatial overlap seen in the im-
ages (Fig. 3b).Please cite this article as: D. Shrestha, et al., CD1d favors MHC neighborhoo
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3.5. Flow-cytometric FRET study among MHC I-HC, β2m, MHC II and CD1d
proteins
To substantiate the ﬁndings from co-localization studies, which only
indicate juxtaposition of molecules, we performed a cell-by-cell FCET
which has been described in detail elsewhere [51], to determine the
physical associations of CD1d and other proteins (MHC I-HC, MHC
II and β2m). FRET results suggested that MHC I-HC, β2m and MHC II
proteins were physically associated with CD1d (Fig. 4b). In addition,
considerably high FRET efﬁciencies were also observed between
these molecular species (Fig. 4a and b). The association of CD1d
with β2m andMHC proteins (MHC I-HC andMHC II) was also detect-
ed by acceptor photobleaching FRET (Supplementary Fig. 1). Inter-
estingly, homoassociation FRET results, a FRET occurring between
the same receptors when labeled proportionally with mixtures of
different conjugates of the same antibody (independent donor and
acceptor conjugates), indicated that both CD1d and MHC II mole-
cules could also exist as dimers or oligomers on the surface of these
cells. However, the ﬂuorescence signals were not enough to reliably
calculate homoassociation FRET for MHC I-HC and β2m proteins
(Fig. 4c).
3.6. Association of CD1d with GM1 gangliosides in C1R–CD1d cells
Peptide antigen presentingMHCmolecules are associated with lipid
enrichedmembrane regions also called rafts in various types of cells, in-
cluding lymphocytes [34,54–57]. In fact, such domains are presumed to
facilitate compartmentalization, promote protein–protein and lipid–
protein interactions on the cell surface [58] and enhance cellular func-
tions, like antigen presentation [28,30,55]. Therefore, we wanted to de-
termine whether CD1d was also enriched in such lipid regions of the
plasma membrane. We probed the relationship between CD1d and
GM1 ganglioside, a frequently used marker for rafts. Our result sug-
gested a high degree of overlap between CD1d and GM1 gangliosides
with a cross-correlation coefﬁcient value of ~0.72. A selected example
is presented in Fig. 5a, which demonstrates the overlapping regions of
CD1d and GM1 gangliosides in pink.
3.7. Effect of cholesterol depletion and TX100 on CD1d rich membrane
regions
The association of CD1d with GM1 gangliosides was further veriﬁed
by FRET. Since cholesterol and sphingolipids are the principal compo-
nents of plasmamembrane,we also tested the effect of cholesterol deple-
tion on the observed association between CD1d and GM1 gangliosides.
Simvastatin, a cholesterol synthesis inhibitor [59], and methyl-β-
cyclodextrin (MβCD), a known membrane cholesterol extractor from
the cell [60],was considered for this purpose. At resting state, a signiﬁcant
FCET result, proving a distinct association, was obtained between CD1d
and GM1 gangliosides. Interestingly, treatment of cells with either
MβCD or simvastatin appeared to have a minor effect on the association
of CD1dwithGM1 subunits, the effectwas not signiﬁcant at the used con-
centrations of reagent based on our study (Fig. 5b). Therefore, we per-
formed FCDR experiments to further characterize these CD1d rich
regions using detergent TX100. We noted that CD1d rich regions were
very sensitive to low concentration of TX100 as depicted in Fig. 6d. Sur-
prisingly, TfR, a non-raft marker abundant in non detergent resistant
membrane regions (DRMs) (see also Supplementary Fig. 2), fared better
than CD1d in terms of tolerance to TX100 (Fig. 6c and d).MHC II proteins,
which are known to partially reside in DRMs, demonstrated superior re-
sistance to TX100 than by TfR proteins (Fig. 6b, c and e). Likewise, the raft
marker GM1 molecules were resilient to TX100 treatment at the
employed concentrations. The tolerance to TX100 for these molecules
was in the following order: GM1NMHC IINTfRNCD1d (Fig. 6). At a typical
concentration of 0.013% TX100, the ﬂuorescence intensities of CD1d de-
creased to ~15%, TfR decreased to ~70%, MHC II decreased to ~80% andd, GM1 ganglioside proximity and low detergent sensitive membrane
ttp://dx.doi.org/10.1016/j.bbagen.2013.10.030
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cline in ﬂuorescence intensity was observed for CD1d among all tested
surfacemarkers. Therefore, mild detergent sensitivity is a speciﬁc feature
of CD1d proteins on the membrane of B lymphocytes.U
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3.8. Effect of MβCD and simvastatin on C1R–CD1d cells in iNKT cell
activation
Studies, primarily based on murine cell lines have demonstrated
contrasting relationships of CD1d with rafts in the plasma membrane.
One of the studies suggested that raft localization of CD1d in antigen
presenting cells (APCs) is essential for signaling through TCR of NKT
cells [28] while another study suggested only a modest effect in the
CD1d mediated antigen presentation ability [61] due to MβCD treat-
ment of APCs. Owing to these discrepancies, we performed similar ex-
periments but on human cell lines using primary iNKT cells. We also
determined the consequences of simvastatin treatment of B cells on
the activation of iNKT cells. We observed that application of 10 mM
MβCD (15 min) to C1R–CD1d cells reduced the membrane expres-
sion of CD1d proteins (28.8 ± 2.3%, Mean ± S.E.M) in C1R–CD1d
cells (Supplementary Fig. 3a); however, this was accompanied by a
greater decrease in the production of both cytokines (IFNγ up to 42%
and IL4 up to 33%) from iNKT cells. Two millimolar MβCD did not
lower the expression of CD1d in C1R–CD1d cells at the used condition
and it had only a modest inhibitory effect on the release of IFNγ and
IL4 by iNKT cells. Interestingly, the reduction in cytokine production
was more prominent in the case of smaller concentration of α-gal
(Fig. 7a and b). Furthermore, despite reports on the negative effect of
simvastatin in APCs in reducing the cytokine release by iNKT cells
[61], we observed that either there is no effect or slight up regulation
in the secretion of cytokines (IL4 and IFNγ) by human iNKT cells upon
treatment of human C1R–CD1d cells with simvastatin (Fig. 7c and d).476
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D3.9. Simvastatin and MβCD alter membrane protein distribution
Biological membranes are semi-ﬂuid in nature with cholesterol
playing a major part in maintaining the integrity of the membrane.
Because, cholesterol affects ﬂuidity and bending stiffness of the mem-
brane, we expected alterations in the membrane protein distribution
of C1R–CD1d cells when treated with MβCD and simvastatin. We
found that both compounds had an effect on the topological arrange-
ment of these proteins in the plasma membrane which means that the
drugs had relevant effects on the cell. As demonstrated in Fig. 8, we
observed changes in FRET efﬁciency between CD1d and MHC proteins,
especially in the case of simvastatin. Interestingly, the association of
MHC I-HC to β2m is signiﬁcantly altered in both the cases. Changes in
FRET efﬁciencies between the proteins complemented the observed ef-
fect in the decrease of CD1d expression in the cells due to the treatment
of these compounds (25.2±1.9%, Mean±S.E.M, decrease inmembrane
CD1d expression due to 10 μM simvastatin, Supplementary Fig. 3b).
Therefore, both compounds alter the distribution ofmembrane proteins
on the surface of C1R–CD1d cells.Fig. 3. Co-localization of receptors: Representative images for each of the receptors used in
co-localization study are presented here. Images at 1.5 μm thickness were scanned from
the top of the membrane of a cell. The images were background subtracted in this ﬁgure.
The ﬁrst two columns in green and red indicates the images of two different molecular
species in pseudo color taken in two different channels of the microscope, and the third
column represents the superimposed image for these two channels. The name of themol-
ecules which were imaged is shown on the bottom right corner of each image. Emission
from Alexa 546 and Alexa 647 dyes were collected through 560/615 nm BP ﬁlter and
650 LP ﬁlter respectively. a) Cells were labeled with antibodies against each of the recep-
tors denoted at the x-axis according to the steps described in the Materials and methods
section. Thereafter, the top of the membrane was used to record numerous images for
each sample from several cells. Next, the co-localization of the two receptors in question
was calculated in terms of cross-correlation coefﬁcient value using the LabView program.
The ﬁrst and second row columns indicate positive and negative control respectively. The
other columns show the ‘C’ values between CD1d and other molecules that were probed
together. The speciﬁc dye conjugated antibodies used are mentioned on the right bottom
of each image in Fig. 3a. For a positive control, the same L243 antibody was conjugated
with both Alexa 546 and Alexa 647 dyeswhile CTxB and TfRmolecules were used for neg-
ative controls.
d, GM1 ganglioside proximity and low detergent sensitive membrane
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Fig. 4. Flow cytometric FRET (FCET). A) Flow cytometric Fret between the proteins: Columns from left to right represent: Positive Control (Gray) — Both A546 and A647 dyes were con-
jugated to the same L243 antibody;β2m served as a donorwhileMHC I-HC (Black) orMHC II (Red) served as an acceptor;MHC I-HC served as a donorwhileβ2m (Green) orMHC II (Blue)
served as an acceptor; CTxB served as a donor while TfR served as an acceptor (Yellow). The FRET pair was always Alexa 546 and Alexa 647 dyes conjugated Mabs except for negative
control where CTxB probes were conjugated with Alexa 555 dyes and were used as donor. Flow cytometric FRET between the proteins: b) Columns from left to right represent: CD1d
served as an acceptor while MHC I-HC (Black) or β2m (Green) or MHC II (Red) served as a donor; MHC II served as an acceptor while CD1d (Blue) served as a donor) Homoassociation
Flow cytometric FRET between the proteins: The proteins are described in the x-axis. r.d) Flow cytometric FRET among three proteins: Columns from left to right represent : (MHC I-
HC + β2m) served as a donor while CD1d (Black) or MHC II (Red) served as an acceptor; (MHC I-HC + CD1d) served as a donor while MHC II (Green) served as an acceptor;
(β2m+CD1d) served as a donor whileMHC II (Yellow) served as an acceptor; β2m served as a donor while (CD1d+MHC II) (Blue) or (CD1d+MHC I-HC) (Pink) served as an acceptor;
MHC I-HC served as a donorwhile (β2m+CD1d) (Gray) served as an acceptor. (Note: Proteinswith ‘+’markmeans theMabs against these receptorswere conjugated to sameAlexa dyes.
For example ‘MHC I-HC+β2m’meansMabs against MHC I-HC and β2mwere conjugated to Alexa 546 independently andwere used in combination as donors for FRET. The same case is
also true for two proteins when used as acceptors except that the Mabs against proteins were conjugated to Alexa 647 dyes.).
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3.10. Multimolecular complexes of CD1d, MHC and lipid species on the
membrane of C1R–CD1d cells
We had no doubts that CD1d and both MHCmolecules were associ-
atedwith each other on the surface of C1R–CD1d cells. Therefore, we as-
sumed that perhaps these molecules can also form a multimolecular
protein complex in the membrane of these cells. To demonstrate such
possibilities, we performed triple co-localization experiments. The co-
occurrence of these proteins was clearly visible, as white pixels, on
the superimposed images. Likewise, overlapping regions were also no-
ticed when two of these proteins were imaged together with GM1 gan-
glioside (Fig. 9). However, the differential propensity of enrichment in
GM1 rich regions was found between MHC I and MHC II proteins.
FRET and co-localization demonstrated that MHC I-HC had a very
weak association with GM1 subunits in comparison with MHC II recep-
tors (Fig. 9, Supplementary Fig. 2 and Supplementary Table 1). Triple
co-localization of proteins demonstrating trimolecular complexes of
proteins was also supported by our two-color but three-protein FCET
experiment. Such a modiﬁed FRET setup would help to predict thePlease cite this article as: D. Shrestha, et al., CD1d favors MHC neighborhoo
regions on the surface of B lymphocytes, Biochim. Biophys. Acta (2013), hpossibilities of trimolecular complexes in comparison with the con-
ventional two-protein FRET pair which only suggests the interaction
of two proteins. With this modiﬁed scheme, the FRET efﬁciency should
increase between two proteins in comparison with conventional two
protein FRET system when a new protein which is generally a part of
trimolecular complex is also included in the FRET pair. In accordance
with such assumptions, we observed an increase in the FRET efﬁciency
between any two proteins with the inclusion of a third protein mainly
withMHC II as acceptor (Fig. 4d). Thus, considering all lines of evidence,
we conclude thatmultimolecular complexes of CD1d and other proteins
(MHC I-HC, β2m and MHC II) are present in the plasma membrane of
these cells, preferably but not exclusively in non-GM1 regions.
4. Discussion
Non-random distribution patterns of MHC I and MHC II proteins in
the plasma membrane have been described in various cell types
[32,33,35,36,53,54,56,62]. The modiﬁcation of these proteins organiza-
tion was also found to occur during several physiological events, ford, GM1 ganglioside proximity and low detergent sensitive membrane
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Fig. 5. CD1d and GM1 ganglioside co-localization: a. Representative image of the distribu-
tion of CD1d and GM1 ganglioside. GM1 gangliosides were labeled with Alexa 488-CTxB
(Blue) and CD1dwas labeledwith Alexa 647–27.1.9 (Red). The overlay image is presented
in the third columnwith pink pixels indicating co-localization. b) Effect of MβCD and Stat-
in in the Relationship between CD1d and GM1 ganglioside: C1R–CD1d cells were treated
withMβCD and simvastatin as described in theMaterials andmethods section. Thereafter,
the cells were labeled with saturating concentrations of CD1d antibodies and CTxB mole-
cules for FCET experiments. CTxB was used as a donor while CD1d protein was used as an
acceptor for FRET. Statistically non-signiﬁcant ‘p’ value is indicated as “N.S.” in the ﬁgure.
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tion [65] and cell differentiation stages [66]. However, to our knowl-
edge, no such report is present till now that has demonstrated the
quiescent state distribution of CD1d protein in the plasma membrane
of B cells. Therefore, using biophysical approaches – including FRET –
for the ﬁrst time we have documented the resting state topological fea-
tures of CD1d in the plasmamembrane of B cells in this study. Quantita-
tive estimation of the number of membrane proteins and evaluation of
FRET efﬁciencies between various protein pairs helped us derive the
proximity relationship among MHC I-HC, β2m, MHC II, and CD1d
proteins. We found that CD1d receptors were physically close to
MHC I-HC, β2m and MHC II proteins on the cell-surface. Though the
physical association of β2m and CD1d is not a new phenomenon,
our data suggest that the proximity between these two proteins is not
entirely dependent on the known non-covalent interactions / or direct
binding of these proteins. Rather, the physical association between
MHC I and CD1d can also spatially position β2m, which are mostly
bound to MHC I, closer to CD1d proteins (Fig. 4). Since both MHC I-HC
and CD1d can interact with β2m proteins, expectedly there was higher
β2m (~40%) in the plasmamembrane of C1R–CD1d “+ve” cells in com-
parison with C1R–CD1d “−ve” cells. However, ﬂow-cytometricFig. 6. Flow cytometry based detergent resistance analysis: The response of various surface mol
were prepared by incubating cells with respective probes independently (see Materials and m
TX100 untreated samples were measured for approximately 50 s, then, ice-cold TX100 at vario
after, the measurement was continued for approximately 5min. a) GM1 subunits b) MHC II pro
ﬂuorescence intensities were averaged for every 60 seconds except for the ﬁrst minute where
addition of TX100 except for untreated samples where continuous measurements for 6min we
experiments and is presented as Mean± S.E.M.
Please cite this article as: D. Shrestha, et al., CD1d favors MHC neighborhoo
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ﬂuorescence histograms and quantitative estimation of membrane pro-
teins in C1R–CD1d “+ve” cells indicated that the total number of β2m
was about 60% of the CD1d proteins expressed in the surface of these
cells. Furthermore, almost the entire MHC I-HC (N99%) population
was in non-covalent interaction with β2m based on HC-10 and W6/32
staining of MHC I protein in C1R–CD1d “+ve” cells (Fig. 1b). Therefore,
the enhanced number of β2m in the plasma membrane of C1R–CD1d
“+ve” cells represents the only fraction of CD1d that is directly bound
with β2m (~15% of membrane CD1d proteins). The occurrence of very
high FRET efﬁciency between β2m and CD1d, MHC I-HC and CD1d,
MHC II and CD1d proteins also strongly implies that these proteins are
the constituents of the same multiprotein complexes. The presence of
such supramolecular complexes should also explain why β2m demon-
strated high FRET efﬁciency with CD1d despite a small fraction of
these proteins being bound to CD1d directly (~15%). It thus advances
the notion that most of the CD1d (~85%) on the surface of C1R–CD1d
cells are not directly bound to β2m. Thismight represent the population
of CD1d which is immature/ or with poor glycosylation modiﬁcations.
This observation also complements the earlier reports in which these
two isoforms were described by biochemical methods [11,67]. Of
note, we did not observe any ﬂuorescence staining due to C3D5 Mab,
an antibody considered to bind only CD1d heavy chain, on the plasma
membrane of C1R–CD1d cells (Data not shown). The inability of this
Mab to bind surface CD1d proteins has been noted before [47,68]. This
suggests that 27.1.9 and 51.1.3 Mabs can bind both isoforms of CD1d
on the cell surface and the non-binding of C3D5 to plasma membrane
CD1d proteins rather indicates the inability of C3D5 Mab to recognize
the conformation of CD1d heavy chain on the plasma membrane or
masking of the epitope recognized by C3D5 or presence of steric hin-
drance due tomultimolecular complexes of proteins on the cell surface.
Thus, it remains a challenge to correctly predict the level of expression
of both isoforms of CD1d (β2m-dependent and β2m-independent
forms of CD1d) on the plasma membrane. Nevertheless, both isoforms
have been identiﬁed in mouse B cells and are found to be capable of ac-
tivating T cells [69]. It is possible that both isoforms may have distinct
functional roles in the activation of T cells. CD1d receptors also
displayed homoassociation FRET, suggesting that CD1d proteins can
also exist as self clusters in the plasma membrane. Previously, atomic
forcemicroscopy (AFM) recognition imaging has revealed the existence
of self clusters of CD1d in the plasma membrane of THP1 monocytic
cells [70,71]. However, AFM imaging of these cells was carried out in
lipid ligand activated monocytic cells. Furthermore, iNKT TCRs were
used to investigate CD1d receptors on the plasma membrane. Lipid
loading on dendritic cells was found to induce the entry of CD1d recep-
tors to DRM regions [30], therefore, the AFM study should have detect-
ed the modiﬁed distribution of CD1d receptors unlike the resting state
distribution of CD1d receptors. The changes in the plasma membrane
distribution of CD1d receptors on lipid loading is also corroborated by
the observation that two different lipid antigens produced two different
patterns of CD1d distribution on the plasma membrane of THP1 cells
[71]. Furthermore, TCRs could only identify lipid bound CD1d receptors.
Hence, our studywith a speciﬁcMab (27.1.9 clone)which can detect in-
dividual CD1d receptors, with or without lipids, is a representation of
the quiescent state distribution of CD1d receptors in B cells. We also ex-
amined the propensity of CD1d towards lipid species using GM1 gangli-
oside at quiescent state. Co-localization and FRET studies indicated the
preference of GM1 rich regions by CD1d proteins. However, cholesterol
depleting agents, MβCD and simvastatin, had only a modest effect on
the association of CD1d with GM1 species based on FRET. Plasmaecules to TX100 treatment is presented as ﬂuorescence intensity versus time. The samples
ethods also). Non-ﬁxed samples were processed for the measurements. Signals from the
us concentrations (untreated, 0.01%, 0.013% and 0.015%) was added to the samples, there-
teins c) TfR d) CD1d proteins e) GM1, MHC II, TfR and CD1d species at 0.013% TX100. The
it was averaged for 45 s. The break in the graph (from 45 to 50 s) represents the point of
re performed. The data for each value is calculated from at least three sets of independent
d, GM1 ganglioside proximity and low detergent sensitive membrane
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d, GM1 ganglioside proximity and low detergent sensitive membrane
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Fig. 7. Effect of MβCD and simvastatin on C1R–CD1d cells in terms of iNKT cell cytokines release: For statistical analyses, either one-way ANOVA together with tukey post-hoc analyses or
unpaired t-test was done. Statistically non-signiﬁcant and signiﬁcant (‘p’b0.05) values are indicated by N.S. and ‘∗’ symbols respectively. Each datumwas normalized by the averaged sum
of all data-sets of the particular independent experiment, including values from both control and treated samples, and is represented asMean±S.E.M. Three ormore independent exper-
iments in triplicates were performed for this study. a. Measurement of IFNγ in the medium after 48h of co-culture between C1R–CD1d cells and iNKT cells. C1R–CD1d cells were loaded
with either 100ng/ml or 1μg/mlα-gal for 18h thereafter itwas washed and treatedwithMβCD. Next, sampleswere ﬁxedwith 1% formaldehyde for 20min in ice before being used in the
co-culture assay. The samples are indicated by the columns in the following colors: Control (Black); 2mMMβCD treated (Red); 10mMMβCD treated (Blue). The amount of IFNγ in control
samples in Mean±S.E.Mwere 1589±402pg/ml (100 ng/mlα-gal culture) and 1642±412pg/ml (1 μg/ml α-gal culture). b. Measurement of IL4 in themedium after 48h of co-culture
between C1R–CD1d cells and iNKT cells. C1R–CD1d cells were loadedwith either 100ng/ml or 1μg/mlα-gal for 18h thereafter itwaswashed and treatedwithMβCD. Next, sampleswere
ﬁxed with 1% formaldehyde for 20min in ice before being used in the co-culture assay. The samples are indicated by the columns in the following colors: Control (Black); 2mM MβCD
treated (Red); 10mM MβCD treated (Blue). The amount of IL4 in control samples in Mean± S.E.M were 551± 153 pg/ml (100 ng/ml α-gal culture) and 604± 109 pg/ml (1 μg/ml α-gal
culture).c. Measurement of IFNγ in themedium after 48h of co-culture between simvastatin treated C1R–CD1d cells and iNKT cells. C1R–CD1d cells were incubated for 48hwith simvastatin
(10μM,Red and20μM,Blue) orwithout simvastatin (Black) either in 1%NCSmedia or 0.5%NCSmedia. Four hours prior to the completion of this incubation period, 250ng/mlα-galwas added
to the C1R–CD1d cells for the loading of iNKT ligand. Next, C1R–CD1d cellswerewashed extensively andwereﬁxed in 1% formaldehyde for 20min on ice. OnlyﬁxedC1R–CD1d cellswere used
in the co-culture assay. Experimentwith 10μMsimvastatin treatment of C1R–CD1d cellswas not performed for 0.5%NCS group. ‘NP’means ‘Not Performed’ in theﬁgure. The amount of IFNγ in
control samples in Mean±S.E.M were 1542±407 pg/ml (1% NCS culture) and 2407±337 pg/ml (0.5% NCS culture).
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Nfrom the plasma membrane, however, the effect of simvastatin mightbe due to its impact on both cholesterol reduction and isoprenoid path-
way. Justifying the secondary effects of simvastatin, it has been reported
earlier that simvastatin could decrease antigen presentation by MHC II
proteins independent of its inhibitory role in the cholesterol biosynthe-
sis [72]. Here, we also observed an increase in GM1 surface expression
due to simvastatin treatment (Data not shown), further indicating it's
another secondary effect. The partial dependence of CD1d rich regions
on cholesterol is also reﬂected by the co-culture assay between
MβCD/simvastatin treated C1R–CD1d cells and iNKT cells. Even on feed-
ing the C1R–CD1d cells with the lipid ligand, α-gal, which induces mi-
gration of CD1d to DRM regions, treatment of C1R–CD1d cells with
MβCD lead to only a modest decrease in cytokine secretion by iNKT
cells. This could be correlated with the partial dependence of CD1d
rich regions on cholesterol in the plasma membrane. However, the sit-
uation appears to be different for simvastatin because we did not seePlease cite this article as: D. Shrestha, et al., CD1d favors MHC neighborhoo
regions on the surface of B lymphocytes, Biochim. Biophys. Acta (2013), hany decrease, rather observed a slight upregulation, in cytokine secre-
tion by iNKT cells despite reduction in the membrane expression of
CD1d in C1R–CD1d cells. Simvastatin decreases the level of membrane
cholesterol (more than 30% reduction in cholesterol, data not shown)
and induces rearrangement of proteins in the plasma membrane. It
also seems to affect the expression level of proteins/lipids in the plasma
membrane which can modify the ﬂuidity of the membrane. Likewise,
simvastatin has been reported to alter the function of small GTPases
[73–76] and was also found to disrupt the actin cytoskeleton [77,78]
in numerous studies. Actin destabilizing agent and Rhokinase inhibitors
were found to enhance antigen presentation by CD1d in murine cells
[79]. Therefore the effects of simvastatin on antigen presentation due
to decrease in CD1d membrane expression and cholesterol depletion
could have been negated by the ability of simvastatin to alter other
biological functions including modiﬁcation of Rho kinase functions
and disruption of actin cytoskeleton. However, it would need furtherd, GM1 ganglioside proximity and low detergent sensitive membrane
ttp://dx.doi.org/10.1016/j.bbagen.2013.10.030
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Fig. 8.MβCD and Simvastatin alter membrane protein distribution: C1R–CD1d cells were
treated with either MβCD (2mM, 40min) or simvastatin (10 μM, 48 h) according to the
optimized protocol (Materials and methods). Thereafter, the samples were prepared for
FCET experiments accordingly. In the ﬁgure, statistically non-signiﬁcant ‘p’ value is indi-
cated as ‘N.S.’, whereas ‘p’ values b0.05, b0.005, and b0.0005 are indicated by ∗, ∗∗, and
∗∗∗ symbols respectively. a) FRET values for control samples are in blackwhileMβCD treat-
ed samples are in red colors. Proteins mentioned below the ticks in x-axis served as a
donor while the one that is under the common line served as acceptor for the FRET exper-
iments. b) FRET values for control samples are in black while simvastatin treated samples
are in red colors. Proteinsmentioned below the ticks in x-axis served as a donor while the
ones that are under the common line served as an acceptor for the FRET experiments.
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investigation to verify such hypothesis. Further, we performed addi-
tional experiments to unravel the speciﬁc nature of CD1d enriched
membrane regions. Interestingly, CD1d rich regions were highly sus-
ceptible to low concentration of TX100 and performed worse than
TfR, whereas, GM1 and MHC II, displayed strong resistance to TX100,
as known for DRM associated markers. Therefore, our results suggest
that either CD1d proteins are localized in the periphery of GM1 gangli-
osides, or are enriched in moderately cholesterol dependent but deter-
gent sensitivemembrane regions of the plasmamembranewhich could
be a distinct raft subtype. Similar features of detergent sensitivity by
CD1d rich regions have also been noted in other cell types [30,80]. Of
note, MHC I proteins are also demonstrated to be present in lowPlease cite this article as: D. Shrestha, et al., CD1d favors MHC neighborhoo
regions on the surface of B lymphocytes, Biochim. Biophys. Acta (2013), hE
D
 P
R
O
O
F
cholesterol containing plasma membrane regions [54] which reﬂects
the feature of CD1d rich regions, however, unlike MHC I which is very
weakly associated with GM1 gangliosides, CD1d shows strong GM1 as-
sociation, a feature of MHC II proteins. Earlier studies based on various
detergents analyses also reinforce the notion that different types of
rafts/ or detergent resistant membrane regions might exist [54,81,82].
In addition, recently cholesterol independent sphingolipid domains,
~200nm in diameter, were highlighted in the plasma membrane of ﬁ-
broblasts. These sphingolipid domains were primarily dependent on
underlying cytoskeletal structures rather than cholesterol [83]. Thus,
the nature of CD1d enriched membrane regions needs further charac-
terization especially by comparing it with MHC enriched domains and
other raft like domains. Remarkably MHC I, MHC II and CD1d species
also demonstrated strong co-occurrence in the plasma membrane.
Furthermore, MHC II and CD1d showed markedly high presence in
GM1 rich regions, whereas, MHC I and CD1d scantily co-distributed in
GM1 regions (Fig. 9). Therefore, these molecules as a supramolecular
complex are present in the plasma membrane although differences
might occur in the abundance of these clusters in GM1 rich or non-
GM1 rich regions. While unraveling the surface organization features
of CD1d receptors, we also found that the plasmamembrane expression
of CD1d would affect the surface expression of MHC proteins. Since
CD1d shares chaperones and invariant chainwithMHCproteins, the ob-
served effect might be related to the competition among these proteins
for these shared proteins in the intracellular compartments. Such as-
sumption is supported by the fact that cells from invariant chain deﬁ-
cient mice have comparatively low cell surface expression of MHC II
proteins and decreased antigen presentation capacity than fromnormal
mice [84,85]. Likewise, expression of CD1a, a subtype of CD1 protein in-
creases the expression of invariant chain in immature dendritic cells
[18]. Therefore, investigating the changes in the expression of invariant
chain and localization of MHC proteins in the cell under such circum-
stances might shed light on such features. In the future, it would be of
advantage to explore the features of CD1d in the plasma membrane
with super-resolution microscopes. These microscopes, like stimulated
emission depletion microscopy and near-ﬁeld scanning optical micro-
scope, are capable of imaging structures beyond the diffraction limit
providing resolution below sub 100 nm, therefore, it can provide far
more insights into the dynamics and nature of molecular interactions
than a conventional confocal microscope. Especially, ﬂuorescence cor-
relation spectroscopy with the aid of these microscopies would be
able to dissect the dynamic relationship between CD1d andGM1 gangli-
osides or rafts. We believe that elucidating these molecular features of
CD1d proteins on the plasma membrane would help us understand
the potential ways how CD1d mediated immune pathways could be
regulated for therapeutic purpose.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbagen.2013.10.030.Acknowledgements
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Fig. 9. Triple color labeling experiment: Three molecules fromMHC I-HC, β2m, MHC II, CD1d and GM1 subunit molecules were labeled simultaneously in similar ways as described in the
Materials and methods section. Once prepared, the ﬁxed samples were washed thoroughly, thereafter; the cells were laid on poly-lysine (0.1mg/ml) coated ibidi chambers. Receptors
were then imaged from the top of the membrane using confocal microscope. Speciﬁc dyes were used for individual receptors, which are indicated at the right bottom of each image.
The last column represents the superimposed image of all the three other columns. Emission from Alexa 488, Alexa 546 and Alexa 647 dyes were collected through 505/550nm BP ﬁlter,
560/615 nm BP ﬁlter and 650 LP ﬁlter respectively.
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